Find Your Broker
Share Name Share Symbol Market Type Share ISIN Share Description
Optibiotix H. LSE:OPTI London Ordinary Share GB00BP0RTP38 ORD 2P
  Price Change % Change Share Price Shares Traded Last Trade
  -1.00p -1.18% 84.00p 32,186 10:14:29
Bid Price Offer Price High Price Low Price Open Price
83.00p 85.00p 86.00p 83.50p 86.00p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 0.19 1.69 2.43 34.6 71.2

Optibiotix H. (OPTI) Latest News

More Optibiotix H. News
Optibiotix H. Takeover Rumours

Optibiotix H. (OPTI) Share Charts

1 Year Optibiotix H. Chart

1 Year Optibiotix H. Chart

1 Month Optibiotix H. Chart

1 Month Optibiotix H. Chart

Intraday Optibiotix H. Chart

Intraday Optibiotix H. Chart

Optibiotix H. (OPTI) Discussions and Chat

Optibiotix H. Forums and Chat

Date Time Title Posts
12/12/201810:11OptiBiotix - Better Science, Better Health. Better buy some!44,049
09/12/201812:15OptiBiotix - The uncensored thread 2,785
16/8/201808:38more sugar vicar?3 Bags full Yes pls!gla27
01/8/201808:21Free Shares1

Add a New Thread

Optibiotix H. (OPTI) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Optibiotix H. trades in real-time

Optibiotix H. (OPTI) Top Chat Posts

Optibiotix H. Daily Update: Optibiotix H. is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker OPTI. The last closing price for Optibiotix H. was 85p.
Optibiotix H. has a 4 week average price of 62p and a 12 week average price of 62p.
The 1 year high share price is 133p while the 1 year low share price is currently 54p.
There are currently 84,724,363 shares in issue and the average daily traded volume is 239,452 shares. The market capitalisation of Optibiotix H. is £70,744,843.11.
riskybusiness1: One last point for the day....Optibiotix is an investment vehicle developing science from R&D to commercial. Once the divisions/businesses have outgrown their level of expertise eg SOH and his scientific background to create the novel products and begin commercialising, they will need more commercially focussed expertise. Per Rehne has been brought in to head the Probiotx health division. For the Probiotix health division to become a £250m+ company they'll need a full team to exploit all the opportunities, especially now with the pharmaceutical market opening up across the pond.Currently Probiotix has only Per as a sole focus to this division. To put this on the back burner and build the value they'll need to put a specific commercial team in place to fully exploit the opportunities leveraging the new teams expertise. They are listing the divisions separately in order do this, leaving Optibiotix as parent co with significant asset value and group revenues.In the next 2 years imo Probiotix health will be listed and will rapidly become more valuable than the current whole of Opti. The Opti share price will then take care of itself as the value is there for all to see in asset and group earnings.Taylor, Elrico has his own group which is far more informative than this thread!forum/lemminginvestors
judijudi: Scotty, He’s done untold harm to the Opti share price for years Imho
danatkins: Value needs to be realised before SBTX divi is released and we are not even close. It makes to laugh when folk bang on about getting their divi. You already have the value of SBTX baked into OPTI share price. So it does not matter about the divi. What matters is the value of your holding and the company fundamentals
onceabroker1: BULLS versus BEARS I am balls deep in OPTI. i basically listen to both sides of the argument on OPTI - the negatives and the positives. Never discount anything. For my own benefit as much as anything else I list the bull versus the bear case. BULLS: i) The micro biome space is set for very high growth. OPTI is at the cutting edge and has a first mover advantage ii) OPTI has proven IP - this is backed up by the fact that as SOH says there has been interest in buying parts of the business iii) OPTI has a diversified business model - it is involved in cholesterol, weight management, sugars and has a 42% stake in skin. It does both B2C and B2B iv) It has a very lean cost base - they don't even have an office. Operating costs are c.£1.5m p/a. This means that any revenue drops to the bottom line v) It has signed c.20 commercial deals in the last 18m and is set to sign many more vi) The recent pharma deal validates the technology and provides a strong reference client to sign up more commercial food supplement deals. The fact that the unnamed pharma company is prepared to fund development of OPTI's strain through FDA trials to commercialisation is testament to the attractiveness of their technology vii) OPTI will start to generate meaningful revenues in Q418/2019. Its "Intel Inside" business model with milestones/licensing revenue/royalties is extremely astute viii) Putting the company on a multiple of 25x (fair for a high growth business) means you only need £3m of profit to justify the current market cap ix) Due to the low cost nature of the business, it is unlikely they will come to the market for more funds. There are only c.80m shares in circulation BEARS: i) OPTI's business is at best a fad at worst a scam. Probiotics don't work ii) OPTI doesn't have any defensible IP and anybody can come in and develop their own strains iii) How can you justify a £75m market cap with no revenues? The share price is a bubble iv) OPTI will have to come to market to raise more money v) Management are unimpressive and unproven. They seem intent on pumping up the share price Thats all I can think of at the moment but I'm sure there are other points for both the bull and the bear cases. Anyway, it seems to me that there are more bull points than bear points. I am a happy holder with a current in price of 93p
greenas1953: Enjoying the rise in the opti share price since I first invested here July 15. And imho there is plenty more to come. I am not surprised rayrac is hurting, his investments have been soul destroying, Monkeywench on the other hand I find truly pathetic a really silly poster doing playground stuff. Good luck all long term holders this is a good share to hold.
kmann: further proving what a pointless product this is. Like all slimming products, false hope for the hopeless. Instructions, eat or drink our product once a day, and you WILL lose weight. Because eating less of anything will cause you to lose weight. EVERY slimming product for years, selling the same message, and most proven to be worthless. Leading to disillusionment, a bit like the opti share price Just eat less, cut out the expensive middleman, and while your at it, do some exercise.
mshilos: In my view, this interview with Opti's CEO throws up a number of red flags whilst the company is valued at £55m but yet to produce any revenues:- hTTp:// 1) Note how often the CEO refers to the share price. CEO should be talking about revenues and profits not the share price. Needless to say, not once are revenues and potential profits mentioned. 2) He appears to think that because peer group companies are highly over-valued then OptiBiotix shares should be highly over-valued too. Ridiculous. It just means the whole sector may be due a nasty surprise. 3) The CEO mentions the whole market opportunity but never once tells investors what slice OptiBiotix are likely to achieve. 4) He keeps referring to growth, but what does he mean since no dates are given regarding revenues let alone profits. What company growth has been achieved then? Headcount and outgoings? 5) CEO says the following :- "The sugars will come much later that's really cutting edge science and that's where the biggest opportunity is". In other words, their biggest market is still light years away. Investors should expect plenty of dilutive placings in the next few years. 6) The first market that they are going to address is the over the counter supplements market. This is a market that is already massively over-crowded. Marketing spend would be huge just to make the slightest penetration. 7) He recognises that Asian markets are a problem. They will just pinch the IP without so much as a by-your-leave. I notice that investors were getting over-excited about a sugar tax today. LOL. See point (5). Revenues and profits are years away yet, and the company is valued at £55m. Who knows what will happen to the share price in the short term, but if I'd made a decent profit already I'd take it off the table because the slightest smell of missed deadlines, disappointments and/or delays with soon smash the share price. There is no margin of safety. Investors will need a constant flow of jam tomorrow RNS's and continued ramping to keep the share price moving forward. Otherwise...............
siennadelekat21: Dire,I'm afraid Monkey is a premium subscriber and as a result advfn will do nothing about him. Before OPTI, he infested the CPX board for ages until the share price actually did well. Hopefully when the OPTI share price moves up further he will eventually move on and infest another board (fingers crossed).Sienna
michaelmouse: 16 March 2016 (start of thread) - Opti share price was 74p. Today it's up 59%. That's about 22% compounded per annum. Pretty good but not spectacular yet!! I wouldn't touch either Opti or Sbtx with a barge pole, but good luck anyway. Overvalued shares getting even more overvalued and a great example of irrational exuberance by the numpties! Both have ridiculous multi-million market caps with next to zero revenues reported. In the end it's always the figures that dictate the share price. See CPT today. I'll watch and wait. Let me know if you take profits. It might be the sensible option at this stage before the bubble bursts. If I was SOH I'd cash in the sbtx shares (if he can sell all his 42%) before the bear market really revs up because (whilst it's difficult to detect) I think this is the start. ;)
parob: I personally don't think SBTX is priced in to the OPTI share price - LPL-DL, SlimBiome, LPGOS, and Sweetbiotix combined are easily worth £100M plus imo. In fact I would have thought announcing a divi of 12p would give the shares a boost! Let's see what comes of these multi-billion turnover company Sweetbiotix deals. If any "cross the product launch line" then a valuation of £100m NOW for Sweetbiotix isn't out of the question. Corporate's will pay huge premiums to block their competitors from market penetration.
Optibiotix H. share price data is direct from the London Stock Exchange
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20181212 10:30:50